IP Library Granted Patent US 12,042,477
Granted Patent B2
US 12,042,477 · App. 15/999,666 · Granted Jul 23, 2024

Dietary product devoid of at least two non essential amino acids

Inventors: Oliver D. K. Maddocks (Glasgow, GB); Karen Vousden (Glasgow, GB)
Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
A61K31/198A61K9/0056A61K9/0095A61K45/06A61P35/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,042,477
App. No.
15/999,666
Granted
Jul 23, 2024
Kind
B2
Abstract

The present invention relates to a dietary product comprising a plurality of amino acids, wherein the dietary product comprises all the essential amino acids and wherein the dietary product is substantially devoid of at least two non-essential amino acids; methods and uses thereof in the treatment of cancer; stratification methods and biomarkers for such applications.

Claims (28)

1. A dietary product comprising:

all essential amino acids, which consist of: histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine, or prodrugs, salts, or esters of said amino acids;

at least three additional amino acids selected from alanine, asparagine, aspartic acid, glutamic acid, glutamine, and proline, or prodrugs, salts, or esters of said amino acids;

and optionally, further comprising one or more of the amino acids tyrosine or arginine, or prodrugs, salts, or esters of said amino acids;

wherein the dietary product is devoid of the amino acids glycine, serine, and cysteine, and prodrugs, salts, and esters of said amino acids.

2. The dietary product of claim 1 , wherein the dietary product is further devoid of arginine, or a prodrug, a salt, or an ester thereof.

3. The dietary product of claim 1 , wherein the dietary product further comprises one or more macronutrients or one or more micronutrients.

4. The dietary product of claim 1 , wherein the dietary product is formulated as a solid.

5. A pharmaceutical composition comprising:

a. the dietary product of claim 1 ; and

b. a pharmaceutically acceptable carrier, a pharmaceutically acceptable excipient, or a pharmaceutically acceptable diluent.

6. The dietary product of claim 1 , wherein the dietary product is further devoid of arginine, or a prodrug, a salt, or an ester thereof, and tyrosine, or a prodrug, a salt, or an ester thereof.

7. The dietary product of claim 1 , wherein the dietary product is further devoid of tyrosine, or a prodrug, a salt, or an ester thereof.

8. The dietary product of claim 1 , wherein the dietary product further comprises methionine, or a salt, or an ester thereof, at a level of less than 25 mg/kg/day.

9. The dietary product of claim 3 , wherein the one or more macronutrient is a fat.

10. The dietary product of claim 3 , wherein the one or more micronutrient is magnesium.

11. The dietary product of claim 3 , wherein the one or more micronutrient is calcium.

12. The dietary product of claim 3 , wherein the one or more micronutrient is potassium.

13. The dietary product of claim 1 , wherein the dietary product is formulated as a beverage.

14. The dietary product of claim 1 , wherein the dietary product comprises alanine, or a prodrug, a salt, or an ester thereof.

15. The dietary product of claim 1 , wherein the dietary product comprises arginine, or a prodrug, a salt, or an ester thereof.

16. The dietary product of claim 1 , wherein the dietary product comprises asparagine, or a prodrug, a salt, or an ester thereof.

17. The dietary product of claim 1 , wherein the dietary product comprises aspartic acid, or a prodrug, a salt, or an ester thereof.

18. The dietary product of claim 1 , wherein the dietary product comprises glutamic acid, or a prodrug, a salt, or an ester thereof.

19. The dietary product of claim 1 , wherein the dietary product comprises glutamine, or a prodrug, a salt, or an ester thereof.

20. The dietary product of claim 1 , wherein the dietary product comprises proline, or a prodrug, a salt, or an ester thereof.

21. The dietary product of claim 1 , wherein the dietary product comprises tyrosine, or a prodrug, a salt, or an ester thereof.

22. The dietary product of claim 1 , wherein the dietary product decreases proliferation rate of a cancer cell.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2020
From: MADDOCKS, OLIVER; VOUSDEN, KAREN
To: CANCER RESEARCH TECHNOLOGY LIMITED
Reel/Frame 054428/0050 →
Priority Claims (2)
GB 1603098 · Feb 23, 2016 · national
GB 1609441 · May 27, 2016 · national
Continuity (1)
Related Publication 20200230092A1 · Jul 23, 2020
Cited By (2)
US 12,220,402 US 12,478,601